Download PDF
Erfahrungsheilkunde 2017; 66(05): 302-314
DOI: 10.1055/s-0043-119017
Praxis
MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart · New York

Mammakarzinom – komplementäre Praxis

Stephan Wey
Further Information

Publication History

Publication Date:
19 October 2017 (online)

    Permissions and Reprints

Zusammenfassung

Komplementäre onkologische Therapieverfahren ergänzen und bereichern die konventionellen Therapien der evidenzbasierten Schulmedizin (OP, Strahlen-, Chemo- und Antihormontherapie u. a.). Dazu gehören Methoden, die in jedem Stadium einer Krebserkrankung sinnvoll in ein koordiniertes Gesamtkonzept durch die behandelnden Chirurgen, Onkologen, Strahlentherapeuten und einem komplementären Arzt eingebettet sein sollten sowie vom Patienten selbst angewendet werden können und die von einer erweiterten Diagnostik über allgemeine Basismaßnahmen über Bewegung und Ernährung bis hin zur Anwendung von orthomolekularen Substanzen, Phytotherapie und sekundärer Pflanzenstoffe sowie weiterer komplementärer Verfahren reichen.

Abstract

Complementary oncological therapies supplement and enrich the conventional therapies of evidence-based orthodox medicine (surgery, radiation therapy, chemotherapy and antihormone therapy etc.). This includes methods, which should be appropriately embedded in a coordinated overall concept by the attending surgeon, oncologist, radiotherapist, and a complementary physician in every stage of a cancer disease, which can be used by the patients themselves, and which range from advanced diagnostics, a general basic measure, exercise and nutrition to the use of orthomolecular substances, phytotherapy and secondary plant substances as well as other complementary procedures.

Schlüsselwörter

Mammakarzinom - Komplementärmedizin - Ernährung - orthomolekulare Medizin - Immunologie

Key words

Mammary carcinoma - complementary medicine - nutrition - orthomolecular medicine - immunology
 

  • Literatur

  • 1 Abbas S, Linseisen J, Slanger T. et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer—results of a large case–control study. Carcinogenesis 2007; 29 (01) 93-99
    CrossrefPubMedGoogle Scholar
  • 2 Adams TD, Hunt SC. Cancer and obesity: effect of bariatric surgery. World journal of surgery 2009; 33: 2028-2033
    CrossrefPubMedGoogle Scholar
  • 3 Albrecht A. „Gefährliche Heiler“ – Wie Alternativ-Mediziner die Not ihrer Patienten ausnutzen. Stern 2014; 28
    PubMedGoogle Scholar
  • 4 Bedogni A, Saia G, Bettini G. et al. Osteomalacia: the missing link in the pathogenesis of bisphosphonate-related osteonecrosis of the jaws?. The oncologist 2012; 17: 1114-1119
    CrossrefPubMedGoogle Scholar
  • 5 Berg PA, Stein GM. Beeinflusst die Misteltherapie die Abwehr epithelialer Tumoren? Eine kritische immunologische Analyse. DMW-Deutsche Medizinische Wochenschrift 2001; 126: 339-345
    PubMedGoogle Scholar
  • 6 Bergman P, Sperneder S, Höijer J. et al. Low vitamin D levels are associated with higher opioid dose in palliative cancer patients–results from an observational study in Sweden. PLoS One 2015; 10 e0128223
    PubMedGoogle Scholar
  • 7 Beuth J. Krebsprävention durch Lebensführung – was ist gesichert?. Best practice onkologie 2013; 8: 6-13
    PubMedGoogle Scholar
  • 8 Beuth J. Proteolytic enzyme therapy in evidence-based complementary oncology: fact or fiction?. Integr Cancer Ther 2008; 7: 311-316
    CrossrefPubMedGoogle Scholar
  • 9 Beuth J, Ost B, Pakdaman A. et al. Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients–results of an epidemiological multicentre retrolective cohort study. Cancer chemotherapy and pharmacology 2001; 47: S45-S54
    CrossrefPubMedGoogle Scholar
  • 10 Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality amoung US adults. Arch Intern Med 2008; 168: 404-10
    CrossrefPubMedGoogle Scholar
  • 11 Bøhn SK, Blomhoff R, Paur I. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Molecular nutrition & food research 2014; 58: 915-930
    CrossrefPubMedGoogle Scholar
  • 12 Bojko P, Schimmel G, Bosse D. et al. Metronomic Oral Cyclophosphamide in Patients with Advanced Solid Tumors. Onkologie 2012; 35: 35-38
    CrossrefPubMedGoogle Scholar
  • 13 Bowers LW. NSAID Use Reduces Breast Cancer Recurrence in Overweight and Obese Women: Role of Prostaglandin–Aromatase Interactions. Cancer Res 2014; 74: 4446-4457
    CrossrefPubMedGoogle Scholar
  • 14 Burd R, Dziedzic TS, Xu Y. et al. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever‐like) whole body hyperthermia. Journal of cellular physiology 1998; 177: 137-147
    CrossrefPubMedGoogle Scholar
  • 15 Calderwood SK, Murshid A, Gong J. Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity. Front Immunol 2012; 3: 75
    PubMedGoogle Scholar
  • 16 Cefak KG. Cefasel: Ergebnisse einer multizentrischen Anwendungsbeobachtung. Beilage zu “Der Bayrische Internist”. 2010
    PubMedGoogle Scholar
  • 17 Chen YC, Sosnoski DM, Gandhi UH. et al. Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer. Carcinogenesis 2009; 30: 1941-1948
    CrossrefPubMedGoogle Scholar
  • 18 Chen Q, Espey MG, Sun AY. et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci 2008; 105: 11105-11109
    CrossrefPubMedGoogle Scholar
  • 19 Chi F. et al. Post-diagnosis soy food intake and breast cancer survival: a metaanalysis of cohort studies. Asian Pac J Cancer Prev 2013; 14: 2407-12
    CrossrefPubMedGoogle Scholar
  • 20 Churilla TM, Brereton HD, Klem M. Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: a community oncology experience. Nutr Cancer 2012; 64: 521-525
    CrossrefPubMedGoogle Scholar
  • 21 Colomer R, Moreno-Nogueira JM, García-Luna PP. et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 2007; 97: 823-831
    CrossrefPubMedGoogle Scholar
  • 22 Cruciani RA, Dvorkin E, Homel P. L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis. Ann NY Acad Sci 2004; 1033: 168-176
    CrossrefPubMedGoogle Scholar
  • 23 Dziaman T, Huzarski T, Gackowski D. et al. Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers. Cancer Epidemiology and Prevention Biomarkers 2009; 18: 2923-2928
    PubMedGoogle Scholar
  • 24 Emond JA. Risk of breast cancer recurrence associated with carbohydrate intake and tissue expression of IGFI receptor. Cancer Epidemiology and Prevention Biomarkers 2014; 23: 1273-1279
    PubMedGoogle Scholar
  • 25 Esposito K, Chiodini P, Colao A. et al. Metabolic Syndrome and Risk of Cancer – A systematic review and meta-analysis. Diabetes Care 2012; 35: 2402-2411
    CrossrefPubMedGoogle Scholar
  • 26 Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nature reviews. Immunology 2015; 15: 335
    CrossrefPubMedGoogle Scholar
  • 27 Fink M. Vitamin D deficiency is a cofactor of chemotherapy-induced mucocutaneous toxicity and dysgeusia. J Clin Oncol 2011; 29: e81-e82
    CrossrefPubMedGoogle Scholar
  • 28 Franca CAS, Nogueira CR, Ramalho A. et al. Serum levels of selenium in patients with breast cancer before and after treatment of external beam radiotherapy. Annals of oncology 2010; 22: 1109-1112
    PubMedGoogle Scholar
  • 29 Friesen C, Addeo R, Caraglia M. et al. D, L-Methadon erhöht den zytotoxischen Effekt konventioneller Krebstherapien. Dtsch Z Onkol 2017; 49: 61-67
    PubMedGoogle Scholar
  • 30 Fritz H. et al. Intravenous Vitamin C and Cancer. A Systematic Review. Integr Cancer Ther 2014; 13: 280-300
    CrossrefPubMedGoogle Scholar
  • 31 Garland CF, Gorham ED, Mohr SB. et al. Vitamin D and prevention of breast cancer: pooled analysis. The Journal of steroid biochemistry and molecular biology 2007; 103 (03) 708-711
    CrossrefPubMedGoogle Scholar
  • 32 Gebauer F, Micheel B, Stauder G. et al. Proteolytic Enzymes Modulate the Adhesion Molecule CD44 on Malignant Cells in Vitro. Int. J. Immunotherapy 1997; 13: 111-119
    PubMedGoogle Scholar
  • 33 Gonzalez CA, Riboli E. Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. European journal of cancer 2010; 46: 2555-2562
    CrossrefPubMedGoogle Scholar
  • 34 Goodwin PJ, Ennis M, Pritchard KI. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009; 27: 3757-3763
    CrossrefPubMedGoogle Scholar
  • 35 Gröber U, Mücke R, Adamietz IA. et al. Komplementärer Einsatz von Antioxidanzien und Mikronährstoffen in der Onkologie. Update 2013. Onkologe 2013; 19: 136-143
    CrossrefPubMedGoogle Scholar
  • 36 Gröber U. Neuroenhancement mit α-Liponsäure. ZKM 2012; 1: 45-49
    PubMedGoogle Scholar
  • 37 Gröber U, Hübner J, Holzhauer P. Vitamin C in der komplementären Onkologie. Onkologe 2010; 16: 303-313
    PubMedGoogle Scholar
  • 38 Harris RE, Beebe-Donk J, Doss H. et al. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade. Oncology Reports 2005; 13: 559-583
    PubMedGoogle Scholar
  • 39 Hong SA, Kim K, Nam SJ. et al. A case–control study on the dietary intake of mushrooms and breast cancer risk among Korean women. International journal of cancer 2008; 122: 919-923
    CrossrefPubMedGoogle Scholar
  • 40 Horsman MR, Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clinical Oncology 2007; 19: 418-426
    CrossrefPubMedGoogle Scholar
  • 41 Jin HW, Flatters SJ, Xiao WH. Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol 2008; 210: 229-237
    CrossrefPubMedGoogle Scholar
  • 42 Jones EL, Oleson JR, Prosnitz LR. et al. Randomized trial of hyperthermia and radiation for superficial tumors. Journal of Clinical Oncology 2005; 23: 3079-3085
    CrossrefPubMedGoogle Scholar
  • 43 Kasseroller RG, Schrauzer GN. Treatment of secondary lymphedema of the arm with physical decongestive therapy and sodium selenite: a review. American journal of therapeutics 2000; 7: 27-279
    PubMedGoogle Scholar
  • 44 Kemper G. Brustkrebs und Umweltbelastungen: Erkennen, verstehen, vermeiden. Dtsch Z Onkol 2016; 48: 29-34
    PubMedGoogle Scholar
  • 45 Khan QJ, Reddy PS, Kimler BF. Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 2010; 119: 111-118
    CrossrefPubMedGoogle Scholar
  • 46 Kim YS. et al. Cancer steam cells: potential target for bioactive food components. J Nutr Biochem 2012; 23: 691-698
    CrossrefPubMedGoogle Scholar
  • 47 Kindler M. Factor AF2 als Begleitmaßnahme zur Chemotherapie – myeloprotektive und antiemetische Wirkungen. Z Onkol 1997; 29: 7-10
    PubMedGoogle Scholar
  • 48 Klingmüller D, Alléra A. Endokrin aktive Substanzen in der Umwelt (Endocrine Disruptors): Gefahr für den Menschen?. DMW-Deutsche Medizinische Wochenschrift 2011; 136: 967-972
    PubMedGoogle Scholar
  • 49 Konklin KA. Coenzyme Q10 for Prevention of Anthracycline-Induced Cardiotoxicity. Integr Cancer Ther 2005; 4: 110-130
    CrossrefPubMedGoogle Scholar
  • 50 Kowalska E, Narod SA, Huzarski T. et al. Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer Epidemiology and Prevention Biomarkers 2005; 14: 1302-1306
    PubMedGoogle Scholar
  • 51 Lappe JM, Travers-Gustafson D, Davies KM. et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-1591
    CrossrefPubMedGoogle Scholar
  • 52 Lee IM, Wolin KY, Freeman SE. et al. Physical activity and survival after cancer diagnosis in men. Journal of Physical Activity and Health 2014; 11: 85-90
    CrossrefPubMedGoogle Scholar
  • 53 Levitsky DO, Dembitsky VM. Anti-breast cancer agents derived from plants. Natural products and bioprospecting 2015; 5: 1-16
    CrossrefPubMedGoogle Scholar
  • 54 Li S, Li Q, Li Y. et al. Acetyl-L-Carnitine in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PloS one 2015; 10: e0119479
    CrossrefPubMedGoogle Scholar
  • 55 Libby G, Donnelly LA, Donnan PT. et al. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes care 2009; 32: 1620-1625
    CrossrefPubMedGoogle Scholar
  • 56 Lin YS, Lin LC, Lin SW. Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow- up of a double-blind randomized study with subgroup analysis. Laryngoscope 2009; 119: 1348-1352
    CrossrefPubMedGoogle Scholar
  • 57 Lipinski B. 2005; Rationale for the treatment of cancer with sodium selenite. Medical hypotheses 64 (04) 806-810
    CrossrefPubMedGoogle Scholar
  • 58 Lippmann SM, Davies PJ. Retinoids, neoplasia and differentiation therapy. Cancer Chemother Biol Response Modif 1997; 17: 349-362
    PubMedGoogle Scholar
  • 59 Liu X, Lv K. Cruciferous vegetables intake is inversely associated with risk of breast cancer: a meta-analysis. The Breast 2013; 22: 309-313
    CrossrefPubMedGoogle Scholar
  • 60 Lopez-Saez JB, Senra-Varela A, Pousa-Estevez L. Selenium in breast cancer. Oncology 2003; 64: 227-231
    CrossrefPubMedGoogle Scholar
  • 61 Magee PJ, Rowland I. Soy products in the management of breast cancer. Current Opinion in Clinical Nutrition & Metabolic Care 2012; 15: 586-591
    CrossrefPubMedGoogle Scholar
  • 62 Mahmoud SM, Paish EC, Powe DG. et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. Journal of clinical oncology 2011; 29: 1949-1955
    CrossrefPubMedGoogle Scholar
  • 63 Messina M. et al. It‘s time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients. Breast Cancer, Oncology Journal. 2013
    PubMedGoogle Scholar
  • 64 Mills E, Wu P, Seely D. et al. Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. Journal of Pineal Research 2005; 39: 360-366
    CrossrefPubMedGoogle Scholar
  • 65 Mohr SB, Gorham ED, Kim J. et al. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer research 2014; 34: 1163-1166
    PubMedGoogle Scholar
  • 66 Moore SC, Lee IM, Weiderpass E. et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA internal medicine 2016; 176: 816-825
    CrossrefPubMedGoogle Scholar
  • 67 Mücke R, Schomburg L, Büntzel J. Komplementärer Seleneinsatz in der Onkologie. Onkologe 2010; 16: 181-186
    CrossrefPubMedGoogle Scholar
  • 68 Münstedt K, Männle H. Grüner Tee zur primären und tertiären Prophylaxe des Mammakarzinoms. Dtsch Z Onkol 2015; 47: 10-12
    PubMedGoogle Scholar
  • 69 Multhoff G, Radons J. Radiation, Inflammation, and Immune Responses in Cancer. Front Oncol 2012; 2: 58
    PubMedGoogle Scholar
  • 70 Nakachi K, Suemasu K, Suga K. et al. Influence of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients. Jpn J Cancer Res 1998; 89: 254-261
    CrossrefPubMedGoogle Scholar
  • 71 Nechuta SJ. et al. Soy food intake after diagnosis of brest cancer and survival: an indepth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr 2012; 96: 123-132
    CrossrefPubMedGoogle Scholar
  • 72 Nechuta S, Lu W, Chen Z. Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2011; 20: 262-271
    CrossrefPubMedGoogle Scholar
  • 73 Notter M, Piazena H, Vaupel P. Hypofractionated re-irradiation of large-sized recurrent breast cancer with thermography-controlled, contact-free water-filtered infra-red-A hyperthermia: a retrospective study of 73 patients. International Journal of Hyperthermia 2017; 33: 227-236
    CrossrefPubMedGoogle Scholar
  • 74 Oh JK, Sandin S, Ström P. et al. Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. International journal of cancer 2015; 137: 1979-1989
    CrossrefPubMedGoogle Scholar
  • 75 Pirouzpanah MB, Sabzichi M, Pirouzpanah S. et al. Silibilin-induces apoptosis in breast cancer cells by modulating p53, p21, Bak and Bcl-XL pathways. Asian Pac J Cancer Prev 2015; 16: 2087-92
    CrossrefPubMedGoogle Scholar
  • 76 Potter GA, Burke MD. Salvestrols – Natural Products with Tumor Selective Activity. J Orthomol Med 2006; 21: 34-36
    PubMedGoogle Scholar
  • 77 Pouchieu C, Galan P, Ducros V. et al. Plasma carotenoids and retinol and overall and breast cancer risk: a nested case-control study. Nutrition and cancer 2014; 66: 980-988
    CrossrefPubMedGoogle Scholar
  • 78 Prieto-Alhambra D, Javaid MK, Servitja S. Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospectiv cohort study. Breast Cancer Res Treat 2011; 125: 869-878
    CrossrefPubMedGoogle Scholar
  • 79 Roffe L, Schmidt K, Ernst E. Efficacy of Coenzyme Q10 for Improved Tolerability of Cancer Treatments: A Systematic Review. J Clin Oncol 2004; 22: 4418-4424
    CrossrefPubMedGoogle Scholar
  • 80 Santini D, Galluzzo S, Vincenzi B. Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients. Ann Oncol 2010; 21: 185-186
    CrossrefPubMedGoogle Scholar
  • 81 Sartippour MR, Shao ZM, Heber D. et al. Green Tea Inhibits Vascular Endothelial Growth Factor (VEGF) Induction in Human Breast Cancer Cells. J Nutr 2002; 132: 2307-2311
    CrossrefPubMedGoogle Scholar
  • 82 Schilling S. Epidemic vitamin D deficiency among patients in an elderly care rehabilitation facility. Dtsch Arztebl Int 2012; 109: 33-38
    PubMedGoogle Scholar
  • 83 Schwaab J, Horisberger K, Erben P. Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. BMC Cancer 2011; 11: 363
    CrossrefPubMedGoogle Scholar
  • 84 Semiglasov VF, Stepula VV, Dudov A. et al. The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer research 2004; 24: 1293-1302
    PubMedGoogle Scholar
  • 85 Singh Sidhu J, Singla R, Jaitak V. Indole derivatives as anticancer agents for breast cancer therapy: a review. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 2016; 16: 160-173
    PubMedGoogle Scholar
  • 86 Sinha D, Biswas J, Sung B. et al. Chemopreventive and Chemotherapeutic Potential of Curcumin in Breast Cancer. Current Drug Targets 2012; 13: 1799-1819
    CrossrefPubMedGoogle Scholar
  • 87 Slivova V, Zaloga G, DeMichele SJ. et al. Green Tea Polyphenols Modulate Secretion of Urokinase Plasminogen Activator (uPA) and Inhibit Invasive Behavior of Breast Cancer Cells. Nutrition and Cancer 2005; 52: 66-73
    CrossrefPubMedGoogle Scholar
  • 88 Solomayer EF, Feuerer M, Bai L. et al. Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer. Clinical Cancer Research 2003; 9: 174-180
    PubMedGoogle Scholar
  • 89 Stoll G. Thymuspeptide in der Onkologie. Z Onkol 1999; 31: 1-7
    PubMedGoogle Scholar
  • 90 Thomson CA, Rock CL, Thompson PA. et al. Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women’s Healthy Eating and Living Study. Breast cancer research and treatment 2011; 125: 519-527
    CrossrefPubMedGoogle Scholar
  • 91 Tröger W, Ždrale Z, Stanković N. Fünf-Jahres-Nachbeobachtung von Patientinnen mit Brustkrebs nach einer randomisierten Studie mit Viscum album (L.) Extrakt. Dtsch Z Onkol 2016; 48: 105-110
    Article in Thieme ConnectPubMedGoogle Scholar
  • 92 Vainio H, Rautalahti M. An international evaluation of the cancer preventive potential of vitamin A. Cancer Epidemiology Biomarkers and Prevention 1999; 8: 107-109
    PubMedGoogle Scholar
  • 93 Verma C, Kaewkangsadan V, Eremin JM. et al. Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery. Journal of translational medicine 2015; 13: 180
    CrossrefPubMedGoogle Scholar
  • 94 Visovsky C, Collins M, Abbott L. et al. Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 2007; 11: 901-913
    CrossrefPubMedGoogle Scholar
  • 95 Vollbracht C, Schneider B, Leendert V. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo 2011; 25: 983-990
    PubMedGoogle Scholar
  • 96 Vormann J. Physiologie und Pathophysiologie von Magnesium. Schw Zeitschr Ernährungsmed 2010; 1: 8-13
    PubMedGoogle Scholar
  • 97 Waldhauer I, Steinle A. NK cells and cancer immunosurveillance. Oncogene 2008; 27: 5932
    CrossrefPubMedGoogle Scholar
  • 98 Wallace JM. Nutritional and Botanical Modulation of the Inflammatory Cascade—Eicosanoids, Cyclooxygenases, and Lipoxygenases— As an Adjunct in Cancer Therapy. Integr Cancer Ther 2002; 1: 7-37
    PubMedGoogle Scholar
  • 99 Walraven I, Riet E, Stehouwer CDA. et al. High proinsulin levels are independently associated with 20-year cancer mortality. The Hoorn study Presentation. Poster Nr. 234 bei 49. EASD-Kongress 2013 in Barcelona.
    PubMedGoogle Scholar
  • 100 Weigelin B, Anderson MD. Activating serial killers: Hyperthermia as supporting strategy for cancer immunotherapy. Vortrag zum VII. Hyperthermie-Kongress, Berlin, September 2016, Zsf in: Aktuelle Gesundheitsnachrichten, Heft 23/2016 der Europäischen Akademie für Naturheilkunde und Umweltmedizin.
    PubMedGoogle Scholar
  • 101 Wey S. L-Carnitin − Porträt einer Aminosäure. Zsf.Orthomol.Med 2015; 2: 19-22
    PubMedGoogle Scholar
  • 102 Wu X, Tang J, Xie M. Serum and hair zinc levels in breast cancer: a meta-analysis. Scientific reports 2015; 5: 12249
    CrossrefPubMedGoogle Scholar
  • 103 Wust P, Hildebrandt B, Sreenivasa G. et al. Hyperthermia in combined treatment of cancer. The Lancet Oncology 2002; 3: 487-497
    CrossrefPubMedGoogle Scholar
  • 104 Zhang L, Conejo-Garcia JR, Katsaros D. et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348: 203-213
    CrossrefPubMedGoogle Scholar
  • 105 Zhang XH, Ma J, Smith-Warner SA. et al. Vitamin B6 and colorectal cancer: Current evidence and future directions. World J Gastroenterol 2013; 19: 1005-1010
    CrossrefPubMedGoogle Scholar
  • 106 Zheng N, Liu L, Liu W. et al. ERβ up-regulation was involved in silibinin-induced growth inhibition of human breast cancer MCF-7 cells. Archives of biochemistry and biophysics 2016; 591: 141-149
    CrossrefPubMedGoogle Scholar